Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Arron

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
JCI Insight|March 11, 2021
Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell populationDaryle J DePianto, Jason A Vander Heiden, Katrina B Morshead, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2009
T-helper type 2-driven inflammation defines major subphenotypes of asthmaPrescott G Woodruff, Barmak Modrek, David F Choy, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2016
Relationships among aeroallergen sensitization, peripheral blood eosinophils, and periostin in pediatric asthma developmentHalie M Anderson, Robert F Lemanske, Joseph R Arron, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2013
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroidsMichael Noonan, Phillip Korenblat, Sofia Mosesova, et al.
JCI Insight|June 19, 2019
TAZ is required for lung alveolar epithelial cell differentiation after injuryTianhe Sun, Zhiyu Huang, Hua Zhang, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2015
IL-13 mediates IL-33-dependent mast cell and type 2 innate lymphoid cell effects on bronchial epithelial cellsDeepti R Nagarkar, Vladimir Ramirez-Carrozzi, David F Choy, et al.
American Journal of Respiratory and Critical Care Medicine|March 9, 2013
Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA studyNicola A Hanania, Sally Wenzel, Karin Rosén, et al.
The European Respiratory Journal|June 25, 2016
Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthmaEmma Doran, David F Choy, Aarti Shikotra, et al.
Frontiers in Immunology|April 21, 2017
Increased Autophagy-Related 5 Gene Expression Is Associated with Collagen Expression in the Airways of Refractory AsthmaticsAudrey H Poon, David F Choy, Fazila Chouiali, et al.
Iscience|October 23, 2023
An interleukin 6 responsive plasma cell signature is associated with disease progression in systemic sclerosis interstitial lung diseaseGuiquan Jia, Thirumalai R Ramalingam, Jason Vander Heiden, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
JCI Insight|March 11, 2021
Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell populationDaryle J DePianto, Jason A Vander Heiden, Katrina B Morshead, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2009
T-helper type 2-driven inflammation defines major subphenotypes of asthmaPrescott G Woodruff, Barmak Modrek, David F Choy, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2016
Relationships among aeroallergen sensitization, peripheral blood eosinophils, and periostin in pediatric asthma developmentHalie M Anderson, Robert F Lemanske, Joseph R Arron, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2013
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroidsMichael Noonan, Phillip Korenblat, Sofia Mosesova, et al.
JCI Insight|June 19, 2019
TAZ is required for lung alveolar epithelial cell differentiation after injuryTianhe Sun, Zhiyu Huang, Hua Zhang, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2015
IL-13 mediates IL-33-dependent mast cell and type 2 innate lymphoid cell effects on bronchial epithelial cellsDeepti R Nagarkar, Vladimir Ramirez-Carrozzi, David F Choy, et al.
American Journal of Respiratory and Critical Care Medicine|March 9, 2013
Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA studyNicola A Hanania, Sally Wenzel, Karin Rosén, et al.
The European Respiratory Journal|June 25, 2016
Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthmaEmma Doran, David F Choy, Aarti Shikotra, et al.
Frontiers in Immunology|April 21, 2017
Increased Autophagy-Related 5 Gene Expression Is Associated with Collagen Expression in the Airways of Refractory AsthmaticsAudrey H Poon, David F Choy, Fazila Chouiali, et al.
Iscience|October 23, 2023
An interleukin 6 responsive plasma cell signature is associated with disease progression in systemic sclerosis interstitial lung diseaseGuiquan Jia, Thirumalai R Ramalingam, Jason Vander Heiden, et al.
Pageof 10